NCT07873580Not yet recruiting
European Implementation Study on Simultaneous Screening for Gastric and Colorectal Cancers
Source: ClinicalTrials.gov · Last updated 14 Oct 2026
Brief summary (registry, in English)
The EUGastScreen study is designed as a quality implementation study to explore gastric cancer screening strategies within organised cancer screening frameworks. The study is set to target individuals who are entering the age range for CRC screening, integrating gastric cancer screening into this existing structure.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 8000 (estimated)
- First submitted
- 24 Sept 2026
- Start date
- Oct 2026
- Primary completion date
- Oct 2027
- Lead sponsor
- University of Latvia
- NCT number
- NCT07873580
What you commit to
- Study type: Observational
- Planned participants: 8000
- From Oct 2026 to the primary completion date, Oct 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- personal history of gastric cancer;
- personal history of colorectal cancer;
- successfully screened via national colorectal cancer screening programme;
Other
- inability or unwillingness to provide informed consent.
Who the study is looking for
- age 50 years and above (the actual recruitment age corresponds to the first CRC-screening age in each participating country/region);
Age in the registry: 50 years to - · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.